All Stories

  1. BMP9 is a key player in endothelial identity and its loss is sufficient to induce arteriovenous malformations
  2. Vasorin as an actor of bone turnover?
  3. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials
  4. VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation
  5. More rapid blood interferon α2 decline in fatal versus surviving COVID-19 patients
  6. Risk factors for thromboembolic events in patients hospitalized for COVID-19 pneumonia in a general ward and requiring treatment with oxygen
  7. Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial
  8. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy
  9. B- and T-lymphocyte attenuator could be a new player in accelerated atherosclerosis associated with chronic kidney disease
  10. Correction: Autophagy protein 5 controls flow-dependent endothelial functions
  11. Association of haemolysis markers, blood viscosity and microcirculation function with organ damage in sickle cell disease in sub‐Saharan Africa (the BIOCADRE study)
  12. Immune response after pig-to-human kidney xenotransplantation: a multimodal phenotyping study
  13. Autophagy protein 5 controls flow-dependent endothelial functions
  14. From bench to bedside: lessons learned from translational podocyte research
  15. Renal control of life-threatening malarial anemia
  16. Type IV Collagen and SOX9 Are Molecular Targets of BET Inhibition in Experimental Glomerulosclerosis
  17. Endothelin blockade prevents the long-term cardiovascular and renal sequelae of acute kidney injury in mice
  18. MicroRNAs in kidney injury and disease
  19. Reply: COVID-19 drug research and the cohort multiple randomised controlled trial design
  20. Vasorin plays a critical role in vascular smooth muscle cells and arterial functions
  21. Should we consider calcimimetics as a therapeutic option for nephrotic syndrome?
  22. ScoMorphoFISH: A deep learning enabled toolbox for single‐cell single‐mRNA quantification and correlative (ultra‐)morphometry
  23. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
  24. FIBER-ML, an Open-Source Supervised Machine Learning Tool for Quantification of Fibrosis in Tissue Sections
  25. The Amphiregulin/EGFR axis protects from lupus nephritis via downregulation of pathogenic CD4+ T helper cell responses
  26. Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group
  27. Effect of interleukin-6 receptor antagonists in critically ill adult patients with COVID-19 pneumonia: two randomised controlled trials of the CORIMUNO-19 Collaborative Group
  28. Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort
  29. A Protective Inter-Organ Communication Response Against Life-Threatening Malarial Anemia
  30. Behavioural immune landscapes of inflammation
  31. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial
  32. Severe COVID-19 is associated with hyperactivation of the alternative complement pathway
  33. PodoSighter: A Cloud-Based Tool for Label-Free Podocyte Detection in Kidney Whole-Slide Images
  34. Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19
  35. Parietal epithelial cell dysfunction in crescentic glomerulonephritis
  36. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
  37. Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
  38. Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs
  39. Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesity
  40. Glomerular Endothelial Cell Crosstalk With Podocytes in Diabetic Kidney Disease
  41. 3D-printed protected face shields for health care workers in Covid-19 pandemic
  42. Calpastatin prevents Angiotensin II-mediated podocyte injury through maintenance of autophagy
  43. Endothelial S1P 1 Signaling Counteracts Infarct Expansion in Ischemic Stroke
  44. Cardiomyopathie toxique induite par l’hydroxychloroquine compliquant le traitement d’un lupus systémique
  45. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
  46. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
  47. Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
  48. Sunitinib-induced cardiac hypertrophy and the endothelin axis
  49. Podocyte healthy self-eating boosted by a spermidine meal?
  50. Cell‐derived microparticles and sickle cell disease chronic vasculopathy in sub‐Saharan Africa: A multinational study
  51. Rôle pathogénique de l’expression anormale de la tétraspanine CD9 par les cellules épithéliales pariétales dans les glomérulopathies extracapillaires
  52. Nuclear receptors in podocyte biology and glomerular disease
  53. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
  54. Amphiregulin Aggravates Glomerulonephritis via Recruitment and Activation of Myeloid Cells
  55. Deletion of the myeloid endothelin-B receptor confers long-term protection from angiotensin II-mediated kidney, eye and vessel injury.
  56. Metabolomic Profiling of Plasma and Erythrocytes in Sickle Mice Points to Altered Nociceptive Pathways
  57. Parietal epithelial cells role in repair versus scarring after glomerular injury
  58. Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients
  59. The proteome of neutrophils in sickle cell disease reveals an unexpected activation of interferon alpha signaling pathway
  60. Histamine provides an original vista on cardiorenal syndrome
  61. Podocytes maintain high basal levels of autophagy independent of mtor signaling
  62. L’hypertension artérielle maligne , un futur prometteur
  63. CELL-Derived Microparticles and Sickle CELL Disease Chronic Vasculopathy in Sub-Saharan Africa
  64. Studying the Determinant of Sickle Cell Disease Vasculopathy in Sub-Saharan Africa : The Biocadre Study
  65. Cellular regeneration of podocytes from parietal cells: the debate is still open
  66. Uncovering the crucial pathogenic role of parietal epithelial cells in severe kidney diseases.
  67. Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing
  68. Posttranslational modifications of sickle hemoglobin in microparticles may promote injury
  69. Local miscommunications between glomerular cells as potential therapeutic targets for crescentic glomerulonephritides
  70. A novel role for myeloid endothelin-B receptors in hypertension
  71. Immunofluorescence Staining of WT-1/Podocalyxin on Mouse Kidney Sections
  72. Imatinib Protects Against Hypoxia/Reoxygenation Induced Lung and Kidney Injury in a Humanized Mouse Model for SCD
  73. Proteomic Landscape of Neutrophils in Sickle Cell Anemia: An Unexpected Autoimmune Profile
  74. Resolution of sickle cell disease associated inflammation and tissue damage with 17R-Resolvin D1
  75. L’inhibition du récepteur de l’EGF sur les cellules immunitaires réduit l’athérosclérose expérimentale
  76. Selective EGF-Receptor Inhibition in CD4+ T Cells Induces Anergy and Limits Atherosclerosis
  77. Selective EGFR (Epidermal Growth Factor Receptor) Deletion in Myeloid Cells Limits Atherosclerosis—Brief Report
  78. Endothelial autophagy as a key mechanism in arterial diseases
  79. Cell cycle unlocking by a microRNA contributes to rapid kidney demolition in autoimmune diseases.
  80. EndothelialEpas1Deficiency Is Sufficient To Promote Parietal Epithelial Cell Activation and FSGS in Experimental Hypertension
  81. Endothelium-Neutrophil Communication via B1-Kinin Receptor–Bearing Microvesicles in Vasculitis
  82. Targeting white blood cells: opportunities for new therapeutics for Sickle Cell Disease.
  83. Targeting mTOR Signaling Can Prevent the Progression of FSGS
  84. Cardiac Metabolic Deregulation Induced by the Tyrosine Kinase Receptor Inhibitor Sunitinib is rescued by Endothelin Receptor Antagonism
  85. Hmox1Deficiency Sensitizes Mice to Peroxynitrite Formation and Diabetic Glomerular Microvascular Injuries
  86. Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1
  87. The Endothelin Receptor Etb Plays a Crucial Role for Recruitment of Neutrophils to the Vascular Wall in Sickle Cell Disease
  88. Sildenafil Prevents Podocyte InjuryviaPPAR-γ–Mediated TRPC6 Inhibition
  89. Autophagy in kidney disease and aging: lessons from rodent models
  90. Platelet and Erythrocyte Sources of S1P Are Redundant for Vascular Development and Homeostasis, but Both Rendered Essential After Plasma S1P Depletion in Anaphylactic ShockNovelty and Significance
  91. Erratum: Erratum: Efficient second-harmonic imaging of collagen in histological slides using Bessel beam excitation
  92. Efficient second-harmonic imaging of collagen in histological slides using Bessel beam excitation
  93. Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage
  94. Identification of the Single Immunodominant Region of the Native Human CC Chemokine Receptor 6 Recognized by Mouse Monoclonal Antibodies
  95. French Intensive Care Society, International congress – Réanimation 2016
  96. Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx
  97. How Is Proteinuric Diabetic Nephropathy Caused by Disturbed Proteostasis and Autophagy in Podocytes?
  98. Delayed Healing of Sickle Cell Ulcers Is due to Impaired Angiogenesis and CXCL12 Secretion in Skin Wounds
  99. A Novel Extrinsic Pathway for the Unfolded Protein Response in the Kidney
  100. Angiogenin Mediates Cell-Autonomous Translational Control under Endoplasmic Reticulum Stress and Attenuates Kidney Injury
  101. Podocyte-Specific Deletion of Murine CXADR Does Not Impair Podocyte Development, Function or Stress Response
  102. Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis
  103. Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor   Essential for Resistance to Crescentic GN
  104. Correction to Multifunctional Rare-Earth Vanadate Nanoparticles: Luminescent Labels, Oxidant Sensors, and MRI Contrast Agents
  105. Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease
  106. ROS Detection and Quantification with Lanthanide-Based Nanosensors
  107. Multifunctional Rare-Earth Vanadate Nanoparticles: Luminescent Labels, Oxidant Sensors, and MRI Contrast Agents
  108. Early renal damage in patients with sickle cell disease in sub-Saharan Africa: a multinational, prospective, cross-sectional study
  109. Genetic Background–Dependent Thrombotic Microangiopathy Is Related to Vascular Endothelial Growth Factor Receptor 2 Signaling during Anti-Glomerular Basement Membrane Glomerulonephritis in Mice
  110. Update on crescentic glomerulonephritis
  111. Lutheran/basal cell adhesion molecule accelerates progression of crescentic glomerulonephritis in mice
  112. Regulation of the ROS Response Dynamics and Organization to PDGF Motile Stimuli Revealed by Single Nanoparticle Imaging
  113. Direct Action of Endothelin-1 on Podocytes Promotes Diabetic Glomerulosclerosis
  114. Atteintes rénales au cours de la drépanocytose
  115. The role of endothelin in glomerular diseases: Cellular culprits, cellular targets
  116. ET-B receptors in podocytes promote diabetic glomerulosclerosis with β-catenin and NFκB activation
  117. A pM inhibitor of HB-EGF derived from diphtheria toxin for the treatment of HB-EGF-related diseases
  118. Transplantation rénale chez deux frères jumeaux monozygotes porteurs d’un polymorphisme G1/G2 de APOL1
  119. Exclusive CX3CR1 dependence of kidney DCs impacts glomerulonephritis progression
  120. L22. Crescent formation: Unraveling local mediators that break glomerular epithelial cell tolerance to immune injury
  121. Analysis of uncoupling protein 2-deficient mice upon anaesthesia and sedation revealed a role for UCP2 in locomotion
  122. Erythrocyte microparticles can induce kidney vaso-occlusions in a murine model of sickle cell disease
  123. Analysis of Uncoupling Protein 2-Deficient Mice upon Anaesthesia and Sedation Revealed a Role for UCP2 in Locomotion
  124. 22. Engineering of an HB-EGF Inhibitor from the Diphtheria Toxin Receptor–Binding Domain for the Treatment of HB-EGF-Related Diseases
  125. How Many Ways Can a Podocyte Die?
  126. Targeting signaling pathways in glomerular diseases
  127. Epidermal growth factor: a new therapeutic target in glomerular disease
  128. Endothelin and the podocyte
  129. Red Blood Cell Sickling During Oxygen Cycles in a Microdroplet Device
  130. Erratum: Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis
  131. Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis
  132. Red Blood Cell Sickling in Microdroplet Arrays
  133. Endothelin in Renal Injury due to Sickle Cell Disease
  134. Endothelin and Podocyte Injury in Chronic Kidney Disease
  135. Response to Angiotensin II Type 1a–Deficient Bone Marrow–Derived Dendritic Cells Produce Higher Levels of Monocyte Chemoattractant Protein 1
  136. Corrigendum
  137. Extracellular matrix alterations in hypertensive vascular remodeling
  138. Glomerular Hyperfiltration in Adult Sickle Cell Anemia: A Frequent Hemolysis Associated Feature
  139. TGF-β activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II–infused mice
  140. Sickling of red blood cells through rapid oxygen exchange in microfluidic drops
  141. A Role for Angiotensin II Type 1 Receptors on Bone Marrow-Derived Cells in the Pathogenesis of Angiotensin II–Dependent Hypertension
  142. Measurement of the quadratic hyperpolarizability of the collagen triple helix and application to second harmonic imaging of natural and biomimetic collagenous tissues
  143. Single europium-doped nanoparticles measure temporal pattern of reactive oxygen species production inside cells
  144. Intracellular detection of Reactive Oxygen Species using single lanthanide nanoparticle imaging: application to vascular signaling
  145. Efficacy of the endothelin receptor blocker bosentan for refractory sickle cell leg ulcers
  146. Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension
  147. Ultrasound Imaging of Renal Vaso-Occlusive Events in Transgenic Sickle Mice Exposed to Hypoxic Stress
  148. Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease
  149. Second harmonic microscopy to quantify renal interstitial fibrosis and arterial remodeling
  150. Variation in natriuretic peptides and mitral flow indexes during successful ventilatory weaning: a preliminary study
  151. Second harmonic imaging and scoring of collagen in fibrotic tissues
  152. Nonlinear microscopy of collagen fibers
  153. Transglutaminase-dependent RhoA Activation and Depletion by Serotonin in Vascular Smooth Muscle Cells
  154. The Dual Endothelin Receptor Antagonist Bosentan Prevents the Acute Sickle Cell-Related Hypoxic Lung and Kidney Injury in Transgenic SAD Mice.
  155. Nouvelle approche des fibroses par microscopie multiphotonique avec génération de second harmonique
  156. Heparin binding EGF is necessary for vasospastic response to endothelin
  157. Transforming Growth Factor-α Mediates Nuclear Factor κB Activation in Strained Arteries
  158. Urinary endothelin-1 as a marker of renal damage in sickle cell disease
  159. EGF receptor activated by HB-EGF is required to calcium influx and vasoconstriction induced by endothelin-1
  160. UCP-2 does not modulate angiotensin II-induced high blood pressure but limits the development of hypertensive renal sclerosis
  161. Exploring type I angiotensin (AT1) receptor functions through gene targeting
  162. Progression and regression in renal vascular and glomerular fibrosis
  163. Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition
  164. Troponin T as a marker of differentiation revealed by proteomic analysis in renal arterioles
  165. Analyse protéomique des protéines impliquées dans le phénotype rénal en hypertension rénovasculaire
  166. Rho Kinase Promotes Alloimmune Responses by Regulating the Proliferation and Structure of T Cells
  167. Epidermal growth factor receptor transactivation mediates the tonic and fibrogenic effects of endothelin in the aortic wall of transgenic mice
  168. Cutaneous microvascular blood flow and reactivity in patients with homozygous sickle cell anaemia
  169. Renal and vascular effects of S21402, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase, in healthy subjects with hypovolemia*
  170. Regression of Renal Vascular Fibrosis by Endothelin Receptor Antagonism
  171. Transgenic Mice as a Tool to Study the Renin-Angiotensin System
  172. Angiotensin II Activates Collagen I Gene Through a Mechanism Involving the MAP/ER Kinase Pathway
  173. Angiotensin II Activates Collagen Type I Gene in the Renal Vasculature of Transgenic Mice During Inhibition of Nitric Oxide Synthesis : Evidence for an Endothelin-Mediated Mechanism
  174. Vascular Endothelin-1 Gene Expression and Synthesis and Effect on Renal Type I Collagen Synthesis and Nephroangiosclerosis During Nitric Oxide Synthase Inhibition in Rats
  175. Activation of renin synthesis is dependent on intact nitric oxide production
  176. Role of αv integrins in mesangial cell adhesion to vitronectin and von Willebrand factor
  177. EGF and TGF-beta regulate neutral endopeptidase expression in renal vascular smooth muscle cells
  178. Interest and limits of in vitro studies in renal vascular endocrinology
  179. Plasma Atrial and Brain Natriuretic Peptides in Mitral Stenosis Treated by Valvulotomy